HIV serostatus disclosure among people living with HIV/AIDS in Mwanza, Tanzania
© Yonah et al.; licensee BioMed Central Ltd. 2014
Received: 26 March 2013
Accepted: 19 January 2014
Published: 22 January 2014
Disclosing HIV serostatus is important for HIV prevention and maintenance of health for people living with HIV their spouses and the community, it plays a role in the social relation which is critical in reducing HIV transmission. The process may have positive and negative effects to the HIV infected people who disclose their status. The present study was undertaken to describe HIV serostatus disclosure among HIV infected people attending care and treatment clinic at Sekou-Toure hospital in Mwanza, Tanzania.
A cross-sectional study was carried out on 270 HIV infected adults attending Care and Treatment Clinic (CTC) at Sekou-Toure hospital between September and October, 2010. A Swahili questionnaire was used to obtain demographic and HIV disclosure information.
Hundred and ninety five (72.5%) of all recruited participants were females, 88.1% (238/270) were aged above 30 years and 44.1% (119/270) were married. The prevalence of serostatus disclosure was 93.3% (252/270) with participants aged above 30 years having significantly higher proportion of serostatus disclosure compared to those aged below 30 years (94.5% vs. 84.4%, p < 0.05). Among the participants who disclosed their status, 69.3% reported closeness to the disclosed person as the reason for disclosure while 25.8% (65/252) disclosed because they needed help. Two hundred (79.4%) reported to have received emotional support following disclosure while 25.8% and 29.7% received financial support and freedom to use their anti-retroviral drugs around the person they disclosed their status respectively. Thirty four participants reported to have been discriminated following disclosure and 12 participants reported to have been divorced.
Rate of disclosure of HIV serostatus was noted to be high in this study. Delayed disclosure was also noted in small proportion of participants. Negative outcomes following disclosure of serostatus were reported by participants. Efforts need to be increased to promote disclosure of HIV serostatus in Tanzania through health education and awareness for both HIV infected individuals and the community.
HIV/AIDS is still a major burden to the health system in Tanzania as it is for other Sub-Sahara African countries. The current estimate for HIV prevalence in Tanzania is 5.6% it is about 1.3% lower than previously reported rate. It is estimated that 1.4 million people are living with HIV in Tanzania with females more affected as compared to their male counterparts.
Prevention of new infection is the cornerstone in the fight against HIV/AIDS. Disclosure of HIV status is an important approach pursued in voluntary testing and counselling (VCT) services. Maman reported 64.5% disclosure among HIV positive women attending VCT clinic in Dar es Salaam-Tanzania. In another study conducted among HIV infected pregnant women in Morogoro, Tanzania 41% had disclosed to their partners.
Studies conducted in Tanzania have reported age, level of education and financial independence particularly for women to be important factors in predicting HIV serostatus disclosure. Kiula et al. in a study conducted in Morogoro, Tanzania reported that HIV-positive women with high level of education, younger and financially independent to be more likely to disclose their serostatus. Lugalla et al. reported women to be less likely to reveal their status to their spouses as compared to men in a study which was conducted among clients attending VCT in Tanzania. In a study conducted by Mwanga et al. among people living with HIV attending care and treatment clinic in Kisarawe, Tanzania disclosure was noted to be similar between males (97.0%) and females (98.5%), however male participants (74.2%) were noted to disclose more to their spouses than female participants (47.7%).
HIV status disclosure has been reported to benefit PLWHA in several ways including psychological, emotional and material support from family and other community members and freedom to use ARV medications[7–9]. HIV transmission occurs between partners including spouses, therefore disclosure of status will provide timely access to care and treatment services in case the partner/spouse is also affected. Uninfected partners in discordant couples will benefit through taking appropriate actions including safer sex practices to prevent acquisition of HIV. Negative outcomes have been attributed to disclosure; these may include rejection, assault, separation, divorce, stigma and discrimination[3, 8]. This study was conducted to examine reasons and effects of HIV serostatus disclosure among PLWHA attending CTC clinic at Sekou-Toure Hospital in Mwanza, Tanzania.
Study design and population
A hospital based cross-sectional study was conducted between September and October, 2010 at Sekou- Toure hospital in Mwanza, Tanzania. A total of 270 (89%) adults living with HIV/AIDS aged 18 years and above who were attending care and treatment clinic for more than six months were recruited. The sample size was determined using proportional formula for calculating sample size; a prevalence of disclosure of 23% from Zimbabwe was utilized for sample size calculation aiming at a power of 80% with a response rate of 90%.
Mwanza is the second largest city in Tanzania located on the Southern shore of Lake Victoria with an estimated population of 2.5 million inhabitants. Sekou-Toure is a regional hospital serving as a referral hospital to five district hospitals. The care and treatment clinic is specific clinic offering services exclusively to HIV infected patients. The clinic is operating daily on working days and it is manned with two clinicians and four nurses. The average patients’ attendance is 40 patients in each clinic day.
Data were collected using pre-tested interviewer-administered Swahili questionnaires which were developed for this study. Participants were recruited consecutively at the CTC clinic during their monthly visits. All consented participants were interviewed in the clinic. Participants were requested to participate voluntarily and no compensation was provided for this study. The information sought included demographic variables which were age, sex, marital status, level of education and occupation. Other information sought from participants included HIV disclosure status, time of disclosure, outcomes following disclosure and reasons for and for not disclosing. Single multiple response questions were asked to determine disclosure status: “Have you ever told anyone about your HIV status?” The person disclosed to was determined by asking: “who was the first person you disclosed your HIV status to?” If the individual had not disclosed his/her HIV status the reasons for not disclosing were explored. Immediate reaction of person disclosed to were probed and the perceived benefits and adverse outcomes were explored from participants. Reasons for not disclosing and outcomes following disclosure were expressed as frequencies according to participants’ responses, more than one response was provided by some participants. Participants were asked if they felt stigmatized and discriminated following disclosure.
This study was approved by the MUHAS ethical review committee. Permission to carry out the study was sought from district health authorities and the hospital management. Participants gave verbal informed consents prior to recruitment into this study.
Epi Info version 6 statistical package was used for data entering, cleaning and analysis. Chi square and Fischer’s exact test were used to determine association between categorical variables. A probability (p) value of ≤0.05 was considered statistically significant.
Prevalence of disclosure status by demographic characteristics among PLWHA (N = 270)
Yes n (%)
No n (%)
< 30 years
> 30 years
No specific job
Distribution of recipients of disclosure and their initial reactions
To whom did you disclose your HIV status first? (N = 252)
What was the reaction of the first person to whom you disclosed your status?(n = 252)†
She/he was shocked
She/he was understanding
She/he laughed at me
Majority of participants 169/252 reported to have disclosed their status because of close relationship to the person they told. Other reasons for disclosing included need for help (65/252) and advice from VCT care providers (28/252). Two hundred and fourteen participants (84.9%) disclosed their status within one month of diagnosis, 14/252 (5.6%) between one to six months and 24/252 (9.5%) disclosed after six months of knowing their HIV status. Reasons given by 18 participants who did not disclose their status included fear of being abandoned by family members reported by six participants, fear of divorce and abandonment by family members (2/18), fear of divorce was reported by only one participant (1/18). Five participants reported that they did not see the importance of disclosing while four did not give any reason.
HIV status disclosure outcome
Positive outcomes (n = 252)
Freedom to use ART
Freedom to use ART and emotional support
Freedom to use ART and financial support
Financial support, freedom to use ART and emotional support
Stigma and discrimination (n = 252)
Divorce (n = 111)†
This study was conducted to determine reasons and effects of HIV serostatus disclosure among PLWHA in Mwanza, Tanzania. Most people living with HIV/AIDS (93.3%) reported to have disclosed their serostatus. Findings from this study are similar to reports by Deribe et al. (94.5%) and Seid et al. (93.1%) from studies conducted among HIV infected men and women using clinical services in Ethiopia[12, 13]. The rate of disclosure was similar between males and females in this study, contrary to reports by Anglewicza et al. and Simbayi et al. in studies conducted in Malawi and South Africa respectively, which noted higher rates of disclosure to sexual partners among female participants as compared to males[14, 15]. Mwanga et al. reported higher proportion of male participants to have disclosed to their sexual partners in a study conducted among CTC clients in Kisarawe district in Tanzania.
Participants aged above 30 years had significantly higher prevalence of serostatus disclosure as compared to those aged below 30 years. Similar findings were reported by Maman et al. and Zou et al. both of which found older age to be a predictor of HIV serostatus disclosure, both studies were carried out in Tanzania[7, 16]. Zou et al. reported older Christians to be more willing to disclose their serostatus if they were found to be HIV positive. Contrary to these findings Kiula et al. reported younger pregnant women to be more likely to disclose their serostatus in a study conducted in Morogoro, Tanzania. The likelihood of disclosure among older participants in our study may be attributed to their maturity and sense of responsibility; however there seem to be a need to explore in depth on the influence of age on HIV serostatus disclosure in Tanzania.
Disclosure to close relative was reported by half of the participants who told their status and only 25% reported spouse as the first person they told their status. This is contrary to report by Lugalla et al. who reported 42% of respondents to have disclosed to their spouses in a study which was conducted among CTC clients who were recruited after completion of testing and counselling in Tanzania. It is possible that married participants in our study disclosed their status to their spouses subsequently; however any delays could have serious implication in the transmission of HIV particularly for discordant couples in events where protective measures like condoms would have not been used during sexual intercourse.
It is encouraging that majority (84.9%) of participants disclosed within six months of knowing their diagnosis. However 15.1% of participants had delayed disclosure similar to 14.2% reported by Deribe et al. in a study conducted among HIV infected men and women using clinical services in Ethiopia. Lugalla et al. reported lower rates of disclosure within the first month of diagnosis in a study conducted among VCT clients in Tanzania in which more than a quarter of the respondents reported disclosure within one month of diagnosis. Delayed disclosure increases the risk of transmission of HIV infections especially when condoms are not used during sexual contact and may downplay the benefits of HIV status disclosure, this may be particularly the case immediately following the receipt of HIV results.
Serostatus disclosure plays an important role in improving quality of life for PLWHA, benefits of serostatus disclosure reported in this study included freedom to use ARV drugs, financial and moral support, similar findings have been reported in literature, Stirratt et al. in a study which was conducted in New York among HIV seropositive patients reported poor adherence to ART among participants who had not disclosed their status. Norman et al. reported financial and emotional support following disclosure from family and community members in a study conducted among PMTCT clients and health care providers in South Africa. Advice and counselling from health care providers were reported to have led to HIV serostatus disclosure among our participants, this finding demonstrate the important role played by health care providers in facilitating HIV status disclosure. Role of health care providers in facilitating disclosure have been previously reported, Kadowa et al. and Mucheto et al. reported counselling and advice from health care providers to predict disclosure in studies conducted among PLWHA in Uganda and Zimbabwe respectively[7, 18–21].
Negative outcomes following HIV serostatus disclosure may result in individuals opting to withhold their status to family, friends and community. Stigma, discrimination and divorce following HIV sero-status disclosure was reported by few participants in this study. This signifies the importance of increasing awareness in our communities to alleviate stigma attached to HIV infection. Separation and divorce have been documented as important factor hindering disclosure, Mucheto et al. reported women who believed disclosure would cause divorce were to be less likely to disclose in a study conducted among HIV infected women attending antenatal and postnatal clinic in Zimbabwe[7, 19, 22]. Couple counselling may be a useful strategy to mitigate spousal rejection and enhance serostatus disclosure in our communities.
This study was based on self-reporting which may have over or underestimated the disclosure status. This was a cross-sectional study therefore some aspects of disclosure could not have been explored adequately. Findings of this study may not be generalizable to the community setting as it was carried out in one health facility.
High rate of HIV disclosure noted in this study is encouraging, however it is important to consider the negative outcomes following disclosure reported in this study. The delay in disclosure and the small proportion of participants who had not disclosed sends an important message to the players in the fights against HIV/AIDS to put emphasis on increasing awareness in the community on the impact of stigma and discrimination. There is a need therefore, to explore factors which are hindering successful and timely disclosure of HIV serostatus in Tanzania.
We are grateful to all participants for taking part in this study. We thank all the staff in the CTC at Sekou-Toure Hospital for assisting in recruitment of study participants. We appreciate financial support for this study form Global Fund (Round 8) which was facilitated by National Institute of Medical Research.
- National Bureau of Statistics, Ministry of Finance and Economic Affairs [Tanzania] : Tanzania HIV and malaria indicator survey. 2007, Available at http://www.nbs.go.tz/tnada/index.php/catalog/9, /2008,
- Tanzania Commission for AIDS Dar es Salaam, Tanzania, (T.), National Bureau of Statistics Dar es Salaam, Tanzania, (N.) and ORC Macro, (O.): Tanzania HIV/AIDS indicator survey 2003-04. Technical report. 2005, Available at http://ihi.eprints.org/id/eprint/669,
- Maman S, Mbwambo JK, Hogan NM, Weiss E, Kilonzo GP, Sweat MD: High rates and positive outcomes of HIV-Serostatus disclosure to sexual partners: reasons for cautious optimism from a voluntary counselling and testing clinic in Dar es Salaam, Tanzania. AIDS Behav. 2003, 7 (4): 373-382.View Article
- Kiula ES, Damian DJ, Msuya SE: Predictors of HIV serostatus disclosure to partners among HIV-positive pregnant women in Morogoro, Tanzania. BMC Public Health. 2013, 13: 433-PubMed CentralView Article
- Lugalla J, Yoderc S, Sigalla H, Madihi C: Social context of disclosing HIV test results in Tanzania. Cult Health Sex. 2012, 14: S53-S66.View Article
- Mwanga JA: HIV serostatus disclosure and associated factors among people living with HIV/AIDS attending a care and treatment centre in Kisarawe District Hospital, Tanzania. 2012, MPH Thesis, Muhimbili University of Health and Allied Sciences, School of Public Health
- Norman A, Chopra M, Kadiyala S: Factors related to HIV disclosure in 2 South African communities. Am J Public Health. 2007, 97: 1775-1781.PubMed CentralView Article
- Ko NY, Lee HC, Hsu ST, Wang WL, Huang MC, Ko WC: Differences in HIV disclosure by modes of transmission in Taiwanese families. AIDS Care. 2007, 19 (6): 791-798.View Article
- Bennetts A, Shaffer N, Manopaiboon C, Chaiyakul P, Siriwasin W, Mock P, Klumthanom K, Sorapipatana S, Yuvasevee C, Jalanchavanapate S, Clark L: Determinants of depression and HIV-related worry among HIV-positive women who have recently given birth, Bangkok, Thailand. Soc Sci Med. 1999, 49: 737-749.View Article
- Farquhar C, Kiarie JN, Richardson BA, Kabura MN, John FN, Nduati RW, Mbori-Ngacha DA, John-Stewart GC: Antenatal Couple Counselling Increases Uptake of Interventions to Prevent HIV-1 Transmission. AIDS. 2001, 15 (6): 815-817.PubMed CentralView Article
- Kangwende RA, Chirenda J, Mudyiradima RF: HIV status disclosure among people living with HIV/AIDS at FASO, Mutare, Zimbabwe. Cent Afr J Med. 2009, 55 (1–4): 1-7.
- Deribe K, Woldemichael K, Wondafrash M, Haile A, Amberbir A: Disclosure experience and associated factors among HIV positive men and women clinical service users in southwest Ethiopia. BMC Public Health. 2008, 8: 81-PubMed CentralView Article
- Seid M, Wasie B, Admassu M: Disclosure of HIV positive result to a sexual partner among adult clinical service users in Kemissie district, northeast Ethiopia. Afr J Reprod Health. 2012, 16 (1): 97-104.
- Anglewicza P, Chintsanya J: Disclosure of HIV status between spouses in rural Malawi. AIDS Care. 2011, 23 (8): 998-1005.View Article
- Simbayi LC, Kalichman SC, Strebel A, Cloete A, Henda N, Mqeketo A: Disclosure of HIV status to sex partners and sexual risk behaviours among HIV-positive men and women, Cape Town, South Africa. Sex Transm Infect. 2007, 83: 29-34.PubMed CentralView Article
- Zou J, Yamanaka Y, John M, Watt M, Ostermann J, Thielman N: Religion and HIV in Tanzania: influence of religious beliefs on HIV stigma, disclosure, and treatment attitudes. BMC Public Health. 2009, 9: 75-PubMed CentralView Article
- Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Kriegar D: The role of HIV Serostatus disclosure in Antiretroviral Medication Adherence. AIDS Behav. 2006, 10: 283-493.View Article
- Kadowa I, Nuwaha F: Factors influencing disclosure of HIV positive status in Mityana district of Uganda. Afr Health Sci. 2009, 9 (1): 26-33.PubMed Central
- Mucheto P, Chadambuka A, Shambira G, Tshimanga M, Notion G, Nyamayaro W: Determinants of nondisclosure of HIV status among women attending the prevention of mother to child transmission programme, Makonde district, Zimbabwe, 2009. Pan Afr Med J. 2011, 8: 51-PubMed Central
- Sowell RL, Seals BF, Philips KD, Julious CH: Disclosure of HIV infection: how do women decide to tell?. Health Educ Res. 2003, 18: 32-44.View Article
- De Rosa C, Marks G: Preventive counselling of HIV positive men and self-disclosure of status to sex partners: new opportunities for prevention. Health Psychol. 1998, 17: 224-231.View Article
- Mlay R, Lugina H, Becker S: Couple counselling and testing for HIV at antenatal clinics: views from men, women and counsellors. AIDS Care. 2008, 20 (3): 356-360.View Article
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.